Biotech

Latest Articles

Chinese blood insulin producer's GLP-1 tops Ozempic in ph. 2

.Chinese the hormone insulin manufacturer Gan &amp Lee Pharmaceuticals is actually falling to the we...

Teva embraces biotech principles as it bends into innovative drug progression, director states

.Amid a reorganization project that is actually revitalized hybrid common and cutting-edge medicatio...

Eli Lilly reveals 2 brand-new proving ground in China

.Eli Lilly is actually increasing its own development probes to Beijing, China, opening two called ...

J &amp J unloads many plans, including ph. 2 Alzheimer's work

.Johnson &amp Johnson is actually jettisoning a number of courses, along with 3 of the culls happeni...

New biotech goals to boost thymus Endurance

.Tissue treatment biotech Altruism Bio has actually revealed with $17.2 million as well as a goal of...

Lundbeck indications $2.5 B check for Longboard and its own epilepsy med

.After snooping hit capacity in Longboard Pharmaceuticals' epilepsy med, mind disease-focused pharma...

Lilly decides on UK for 1st Gateway Laboratory in Europe

.Eli Lilly's Entrance Labs is going international, with the U.K. federal government declaring today ...

Jasper dials up dose after hives responses come and go promptly

.Jasper Rehab has mentioned full reactions in 10 of the 12 constant hives people that obtained the h...

Transgene's viral cancer vaccine flunks midphase exam

.Transgene's curative vaccination candidate TG4001 has actually failed a stage 2 sound tumor trial. ...

Upstream swells IPO to $255M as it lists along with CAMP4

.Upstream Bio possesses inflamed its own IPO to $255 million as the provider signs up with CAMP4 Reh...

Sanofi flunks MS research, inflicting one more impact to Denali contract

.Sanofi has quit a stage 2 hardship of Denali Therapeutics-partnered oditrasertib in a number of scl...

Turnstone gives up 60%, shakes up C-suite to stretch out cash money

.Turnstone Biologics is actually lowering its own headcount by 60% and shaking up its C-suite so as ...

Gilead loses hope on $15M MASH wager after weighing preclinical information

.In a year that has actually observed an authorization and a range of readouts for metabolic dysfunc...

Texas biotech centers cancer cells treaty, pins hopes on excessive weight

.Alaunos Rehabs is axing a contract with Precigen, quiting licensing rights to a personalized T-cell...

Capricor allotments much more records for DMD therapy after starting BLA

.Capricor Therapies is actually taking a triumph tour for their phase 2 Duchenne muscle dystrophy (D...

FDA locations Kezar lupus trial in hold observing 4 client deaths

.The FDA has put Kezar Lifestyle Sciences' lupus trial on hold after the biotech flagged 4 fatalitie...

Phase 3 Historian Stone trial reaches SMA target, delivering stockpile 200%

.A stage 3 test of Academic Stone's spinal muscle atrophy (SMA) prospect has actually reached its ow...

CAMP 4 is most current to eye IPO, while Upstream define $182M plan

.RNA biotech CAMP4 Rehabs has defined plans for a $67 million IPO, along with inflammation-focused U...

Galecto acquires leukemia drug, goes down bone tissue cancer cells asset in pivot

.A year after the failing of an idiopathic lung fibrosis candidate sent out Galecto on a hunt for sa...

Judo tosses down $100M to knock senseless kidney illness

.Taking the floor covering is Judo Bio, a promising biotech armed with $one hundred thousand to crea...